ST3GAL1 and triple-negative breast carcinoma: In addition to ST3GAL1, the elevated levels of ST3GAL2 and its product sialyl-glycolipid stage-specific embryonic antigen 4 (SSEA4) were suggested for the increased chemoresistance of triple-negative breast cancer to genotoxic agents (Aloia et al., 2015).